Literature DB >> 28616120

New research in kidney cancer, ASCO-GU 2017.

Naveen Basappa1, Frederic Pouliot2.   

Abstract

Entities:  

Year:  2017        PMID： 28616120      PMCID： PMC5461154          DOI： 10.5489/cuaj.4607

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  1 in total

1.  Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.

Authors:  Daniel Y C Heng; J Connor Wells; Brian I Rini; Benoit Beuselinck; Jae-Lyun Lee; Jennifer J Knox; Georg A Bjarnason; Sumanta Kumar Pal; Christian K Kollmannsberger; Takeshi Yuasa; Sandy Srinivas; Frede Donskov; Aristotelis Bamias; Lori A Wood; D Scott Ernst; Neeraj Agarwal; Ulka N Vaishampayan; Sun Young Rha; Jenny J Kim; Toni K Choueiri
Journal:  Eur Urol       Date:  2014-06-13       Impact factor: 20.096
  1 in total
  3 in total

1.  NudCD1 affects renal cell carcinoma through regulating LIS1/Dynein signaling pathway.

Authors:  Hongchao He; Jun Dai; Xiaojing Wang; Xiaoqiang Qian; Juping Zhao; Haofei Wang; Danfeng Xu
Journal:  Am J Transl Res       Date:  2018-02-15       Impact factor: 4.060

2.  Luminescent Analysis of Blood Serum for Diagnostics of Pathological and Pre-Pathological States of Cancer Patients.

Authors:  Marina Bondarenko; Olga Zaytseva; Valeriya Trusova; Anton Moiseenko; Aleksey Rukin; Tetyana Utytskykh; Oksana Morozova
Journal:  J Fluoresc       Date:  2021-05-06       Impact factor: 2.217

Review 3.  Tackling Cancer Resistance by Immunotherapy: Updated Clinical Impact and Safety of PD-1/PD-L1 Inhibitors.

Authors:  Shifaa M Abdin; Dana M Zaher; El-Shaimaa A Arafa; Hany A Omar
Journal:  Cancers (Basel)       Date:  2018-01-25       Impact factor: 6.639
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.